These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8855610)
41. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Engmann L; Sladkevicius P; Agrawal R; Bekir JS; Campbell S; Tan SL Fertil Steril; 1999 Jan; 71(1):22-9. PubMed ID: 9935111 [TBL] [Abstract][Full Text] [Related]
43. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Smotrich DB; Widra EA; Gindoff PR; Levy MJ; Hall JL; Stillman RJ Fertil Steril; 1995 Dec; 64(6):1136-40. PubMed ID: 7589666 [TBL] [Abstract][Full Text] [Related]
44. Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol. Gürgan T; Urman B; Yarali H; Duran HE Fertil Steril; 1997 Sep; 68(3):483-7. PubMed ID: 9314919 [TBL] [Abstract][Full Text] [Related]
45. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Frattarelli JL; Lauria-Costab DF; Miller BT; Bergh PA; Scott RT Fertil Steril; 2000 Sep; 74(3):512-7. PubMed ID: 10973648 [TBL] [Abstract][Full Text] [Related]
46. [Variations in the molecular forms of LH and FSH during the normal ovarian cycle]. Hernandez-Valencia M; Mason M; Eugenia Fonseca M; Zarate A Ginecol Obstet Mex; 1996 Mar; 64():140-5. PubMed ID: 8729192 [TBL] [Abstract][Full Text] [Related]
47. An increased initial follicle-stimulating hormone/luteinizing hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilization. Benadiva CA; Ben-Rafael Z; Blasco L; Tureck R; Mastroianni L; Flickinger GL Fertil Steril; 1988 Nov; 50(5):777-81. PubMed ID: 3141220 [TBL] [Abstract][Full Text] [Related]
48. Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization. van der Stege JG; van der Linden PJ Gynecol Obstet Invest; 2001; 52(1):43-6. PubMed ID: 11549863 [TBL] [Abstract][Full Text] [Related]
49. [Basal fsh level is only predictive of the quantitative aspect of the ovarian response]. Fourati S; Merdassi G; Khrouf M; Elloumi H; Fadhlaoui A; Brahmi I; Hammami N; Ben Slima S; Ben Meftah M; Zhioua F; Zhioua A Tunis Med; 2012 Jul; 90(7):524-9. PubMed ID: 22811225 [TBL] [Abstract][Full Text] [Related]
50. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Sharif K; Elgendy M; Lashen H; Afnan M Br J Obstet Gynaecol; 1998 Jan; 105(1):107-12. PubMed ID: 9442172 [TBL] [Abstract][Full Text] [Related]
51. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Khalifa E; Toner JP; Muasher SJ; Acosta AA Fertil Steril; 1992 Apr; 57(4):835-9. PubMed ID: 1555696 [TBL] [Abstract][Full Text] [Related]
52. Relationship of early follicular phase sera follicle stimulating hormone and luteinizing hormone levels as measured by a radioimmunoassay and an enzyme-linked immunosorbent assay to number of oocytes retrieved. Check JH; Nazari A; Kuhn R; Lauer C Clin Exp Obstet Gynecol; 1996; 23(2):83-6. PubMed ID: 8737619 [TBL] [Abstract][Full Text] [Related]
53. [Overview of cancellations between November 2004 and March 2005 at the Antoine-Béclère hospital]. Frydman R J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 2):5S10-5S13. PubMed ID: 16340896 [TBL] [Abstract][Full Text] [Related]
54. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Evers JL; Slaats P; Land JA; Dumoulin JC; Dunselman GA Fertil Steril; 1998 Jun; 69(6):1010-4. PubMed ID: 9627285 [TBL] [Abstract][Full Text] [Related]
55. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Toner JP; Philput CB; Jones GS; Muasher SJ Fertil Steril; 1991 Apr; 55(4):784-91. PubMed ID: 1901282 [TBL] [Abstract][Full Text] [Related]
56. The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response. Akande VA; Keay SD; Hunt LP; Mathur RS; Jenkins JM; Cahill DJ J Assist Reprod Genet; 2004 Jul; 21(7):257-62. PubMed ID: 15526983 [TBL] [Abstract][Full Text] [Related]
57. The significance of elevated FSH for reproductive function. Toner JP Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):283-95. PubMed ID: 8358891 [TBL] [Abstract][Full Text] [Related]
58. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Yanushpolsky EH; Hurwitz S; Tikh E; Racowsky C Fertil Steril; 2003 Jul; 80(1):111-5. PubMed ID: 12849811 [TBL] [Abstract][Full Text] [Related]
59. [Clinical and laboratory evaluation of prolonged administration of microdoses of d-Norgestrel]. Werbrouck-Navette J; Godts PJ; Plomteux G; Franchimont P Rev Fr Gynecol Obstet; 1974 Nov; 69(11):627-33. PubMed ID: 4463447 [TBL] [Abstract][Full Text] [Related]